MIRM

News Mirum (MIRM) Soars on Interim Data From Liver Disease Studies

14d ago

News Mirum's (MIRM) Livmarli Aids Sales but Overdependence Concerns

14d ago

SEC filing MIRM Plans $600M Convertible Senior Notes Offering, Grants $90M Overallotment Option, to Use Proceeds for General Corporate Purposes and Note Exchange Transactions

15d ago

News Mirum Pharmaceuticals prices $600M senior notes

20d ago

News Mirum raises 2026 net product sales outlook to $660M-$680M as it targets year-end zilurgisertib launch

26d ago

SEC filing MIRM Reports 2.72-Point Pruritus Improvement, 1.64-Point Placebo Difference, 55.6% ≥2-Point Reduction, FDA Meeting Set for Summer 2026

29d ago

SEC filing MIRM Reports 100% Virologic Response in 300mg QW Arm, 75% in 900mg Q4W, Phase 2b AZURE-1 Meets Primary Endpoint

36d ago

Insider trade Sale by Saira Ramasastry

46d ago

SEC filing MIRM Reports $0 Revenue, -$1.2B Net Loss, 2025 Audit Finds Substantial Doubt on Going Concern

55d ago

Insider trade Sale by Saira Ramasastry

76d ago

Insider trade Sale by Christopher Peetz (CHIEF EXECUTIVE OFFICER)

76d ago

Insider trade Sale by Peter Radovich (PRESIDENT AND COO)

76d ago

Insider trade Sale by Joanne Quan (CHIEF MEDICAL OFFICER)

76d ago

Insider trade Sale by Jolanda Howe (SVP, GLOBAL CONTROLLER)

76d ago

Insider trade Sale by Eric Bjerkholt (CHIEF FINANCIAL OFFICER)

76d ago

Insider trade Sale by Saira Ramasastry

104d ago

Insider trade Sale by Peter Radovich (PRESIDENT AND COO)

104d ago

Insider trade Sale by Christopher Peetz (CHIEF EXECUTIVE OFFICER)

104d ago

Insider trade Sale by Jolanda Howe (SVP, GLOBAL CONTROLLER)

104d ago

Insider trade Sale by Saira Ramasastry

104d ago

Insider trade Sale by Joanne Quan

104d ago

Insider trade Sale by Christopher Peetz

104d ago

Insider trade Sale by Jolanda Howe

104d ago

Insider trade Sale by Joanne Quan

104d ago

Insider trade Sale by Peter Radovich

104d ago